NCT06139835

Brief Summary

This study was designed to find our whether a novel toothpaste containing safe digestive enzymes (Tartarase) was able to remove pre-existing dental tartar when compared to a well-known toothpaste (Crest). A group of 40 test subjects that had at lease 9 mm of tartar on the tongue side of the 6 lower front teeth, were randomly divided into 3 groups unknown to the the team overseeing the measurements. All the groups brushed with a toothbrush approved by the American Dental Association. Group A (20 subject) was the control group. They brushed in the morning and before bed with Crest for 2 minutes. Group B (10 subjects) brushed in the morning and before bed using the same procedure, first with Tartarase for 30 seconds, spit, but did not rinse, then repeated. After 30 minutes then brushed with Crest. Group C (10 subjects) brushed for 30 seconds with Tartarase, spit but did not rinse, then filled a dental tray with Tartarase and covered the 6 lower front teeth and waited 30 minutes, spit but did not rinse and brushed for ann additional 30 seconds with Tartarase. After 30 minutes they brushed with Crest. They brushed with crest before bed, without another Tartarase treatment. The study was a 4-week study, with tartar measured at the start (baseline), again after 2 weeks and again at the final study point of 4 weeks. If any of the study subjects experienced anything unpleasant, they were to inform the team overseeing the study. The tartar measurements were compiled into the 3 groups and statistically analyzed to determine if there were any changes in the amount of tartar within the groups and between the groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
37

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 8, 2022

Completed
28 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 6, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 6, 2022

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

November 14, 2023

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 18, 2023

Completed
Last Updated

November 18, 2023

Status Verified

November 1, 2023

Enrollment Period

28 days

First QC Date

November 14, 2023

Last Update Submit

November 14, 2023

Conditions

Keywords

gingivitisdentifriceplaque

Outcome Measures

Primary Outcomes (1)

  • Tartarase Efficacy

    Assess the change in calculus abundance measured by the V-MI in groups brushing with Crest, the Tartarase brushing group and the Tartarase tray group.

    4 weeks

Study Arms (3)

Control

ACTIVE COMPARATOR

Individuals randomly assigned to the control arm where they brushed their teeth with a popular toothpaste (crest) in the morning and before bed. This routine was repeated daily for 4 weeks.

Biological: Tartarase

Tartarase brushing

EXPERIMENTAL

In the morning, this group brushed with Tartarase for 30 seconds, spit, but did not rinse and repeated the process. In 30 minutes they brushed with Crest. They repeated this routine before bed. This routine was repeated daily for 4 weeks.

Biological: Tartarase

Tartarase tray

EXPERIMENTAL

In the morning this group brushed with Tartarase for 30 seconds, filled a dental tray with Tartarase and applied it to the 6 lower front teeth and left it for 30 minutes, spit but did not rinse then brushed with Tartarase for another 30 seconds, spit, but did not rinse. In 30 minutes they brushed with Crest. Before bed they brushed with Crest alone. This routine was repeated daily for 4 weeks.

Biological: Tartarase

Interventions

TartaraseBIOLOGICAL

Brushing with a formulation containing DNase 1 and chymotrypsin to assess its efficacy at removing accumulated calculus

ControlTartarase brushingTartarase tray

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • In order to be included in the study, each subject must have:
  • Provided written informed consent to participate in the study;
  • Adult subjects aged 18 years and older, that were in good health;
  • Agreed not to participate in any other oral/dental product studies during the course of this study and used only the assigned oral hygiene products during the entire study (including toothbrushes, toothpastes, home remedies, floss or other products like chewing gum, mouthwashes, tongue cleaners, etc.);
  • Agreed to refrain from the use of any elective dentistry (including a non-study dental prophylaxis) until the study had been completed;
  • Agreed to refrain from the use of any non-study oral hygiene and whitening products;
  • Been in good general health, as determined by the investigator/designee based on a review of the health history/update for participation in the study;
  • Had six mandibular anterior teeth with no crowns or veneers;
  • Agreed to comply with the study procedures and schedule, including the follow up visits;
  • Had at least 9mm of dental calculus on the mandibular anterior six teeth and reported that they had received a dental cleaning in previous 2-6 months.
  • Healthy Volunteers

You may not qualify if:

  • Had a medical condition requiring antibiotic premedication prior to dental procedures;
  • Regularly used chlorhexidine mouth rinse;
  • Had any oral condition or pathosis that could interfere with study compliance and/or examination procedures (e.g., widespread caries, chronic neglect, advanced periodontal disease);
  • Had current or history of oral cavity cancer or oropharyngeal cancer;
  • Were pregnant or nursing by subject report;
  • Did not brush regularly;
  • Had any condition that might have made it unsafe for the subject to participate in this study, at the discretion of the investigator.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pontis Biologics, Inc

Huntington, New York, 11743, United States

Location

Related Publications (2)

  • VOLPE AR, MANHOLD JH, HAZEN SP. IN VIVO CALCULUS ASSESSMENT. I. A METHOD AND ITS EXAMINER REPRODUCIBILITY. J Periodontol (1930). 1965 Jul-Aug;36:292-8. doi: 10.1902/jop.1965.36.4.292. No abstract available.

  • Milleman KR, Deener G, Milleman JL, Mish B, Schuller R, Mynarcik D. A proof of principle investigation of a novel enzyme formulation on dental calculus deposition: a 4-week randomized human clinical trial. BMC Oral Health. 2024 Jun 22;24(1):720. doi: 10.1186/s12903-024-04498-x.

MeSH Terms

Conditions

Dental CalculusGingivitisPlaque, Amyloid

Condition Hierarchy (Ancestors)

Dental DepositsTooth DiseasesStomatognathic DiseasesCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsInfectionsGingival DiseasesPeriodontal DiseasesMouth Diseases

Study Officials

  • Dennis C. Mynarcik, PhD

    Pontis Biologics, Inc.

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Masking Details
The group of study subjects, selected from the study site's database were randomized by the statistician into three different treatment groups. The personnel performing the measurements were blinded as to which group the study subjects we in.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Comparison of the change in calculus abundance of two treatment groups, using the same dentifrice with two different methods of application with a control group using a popular standard dentifrice.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 14, 2023

First Posted

November 18, 2023

Study Start

June 8, 2022

Primary Completion

July 6, 2022

Study Completion

July 6, 2022

Last Updated

November 18, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations